Literature DB >> 32267237

A Hematologist-Level Deep Learning Algorithm (BMSNet) for Assessing the Morphologies of Single Nuclear Balls in Bone Marrow Smears: Algorithm Development.

Yi-Ying Wu1, Tzu-Chuan Huang1, Ren-Hua Ye1, Wen-Hui Fang2, Shiue-Wei Lai1, Ping-Ying Chang1, Wei-Nung Liu1, Tai-Yu Kuo1, Cho-Hao Lee1, Wen-Chiuan Tsai3, Chin Lin4,5.   

Abstract

BACKGROUND: Bone marrow aspiration and biopsy remain the gold standard for the diagnosis of hematological diseases despite the development of flow cytometry (FCM) and molecular and gene analyses. However, the interpretation of the results is laborious and operator dependent. Furthermore, the obtained results exhibit inter- and intravariations among specialists. Therefore, it is important to develop a more objective and automated analysis system. Several deep learning models have been developed and applied in medical image analysis but not in the field of hematological histology, especially for bone marrow smear applications.
OBJECTIVE: The aim of this study was to develop a deep learning model (BMSNet) for assisting hematologists in the interpretation of bone marrow smears for faster diagnosis and disease monitoring.
METHODS: From January 1, 2016, to December 31, 2018, 122 bone marrow smears were photographed and divided into a development cohort (N=42), a validation cohort (N=70), and a competition cohort (N=10). The development cohort included 17,319 annotated cells from 291 high-resolution photos. In total, 20 photos were taken for each patient in the validation cohort and the competition cohort. This study included eight annotation categories: erythroid, blasts, myeloid, lymphoid, plasma cells, monocyte, megakaryocyte, and unable to identify. BMSNet is a convolutional neural network with the YOLO v3 architecture, which detects and classifies single cells in a single model. Six visiting staff members participated in a human-machine competition, and the results from the FCM were regarded as the ground truth.
RESULTS: In the development cohort, according to 6-fold cross-validation, the average precision of the bounding box prediction without consideration of the classification is 67.4%. After removing the bounding box prediction error, the precision and recall of BMSNet were similar to those of the hematologists in most categories. In detecting more than 5% of blasts in the validation cohort, the area under the curve (AUC) of BMSNet (0.948) was higher than the AUC of the hematologists (0.929) but lower than the AUC of the pathologists (0.985). In detecting more than 20% of blasts, the AUCs of the hematologists (0.981) and pathologists (0.980) were similar and were higher than the AUC of BMSNet (0.942). Further analysis showed that the performance difference could be attributed to the myelodysplastic syndrome cases. In the competition cohort, the mean value of the correlations between BMSNet and FCM was 0.960, and the mean values of the correlations between the visiting staff and FCM ranged between 0.952 and 0.990.
CONCLUSIONS: Our deep learning model can assist hematologists in interpreting bone marrow smears by facilitating and accelerating the detection of hematopoietic cells. However, a detailed morphological interpretation still requires trained hematologists. ©Yi-Ying Wu, Tzu-Chuan Huang, Ren-Hua Ye, Wen-Hui Fang, Shiue-Wei Lai, Ping-Ying Chang, Wei-Nung Liu, Tai-Yu Kuo, Cho-Hao Lee, Wen-Chiuan Tsai, Chin Lin. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 08.04.2020.

Entities:  

Keywords:  artificial intelligence; bone marrow examination; deep learning; leukemia; myelodysplastic syndrome

Year:  2020        PMID: 32267237     DOI: 10.2196/15963

Source DB:  PubMed          Journal:  JMIR Med Inform


  8 in total

1.  Efficient and Highly Accurate Diagnosis of Malignant Hematological Diseases Based on Whole-Slide Images Using Deep Learning.

Authors:  Chong Wang; Xiu-Li Wei; Chen-Xi Li; Yang-Zhen Wang; Yang Wu; Yan-Xiang Niu; Chen Zhang; Yi Yu
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

2.  Automated bone marrow cytology using deep learning to generate a histogram of cell types.

Authors:  Rohollah Moosavi Tayebi; Youqing Mu; Taher Dehkharghanian; Catherine Ross; Monalisa Sur; Ronan Foley; Hamid R Tizhoosh; Clinton J V Campbell
Journal:  Commun Med (Lond)       Date:  2022-04-20

3.  Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients.

Authors:  Korsuk Sirinukunwattana; Alan Aberdeen; Helen Theissen; Nikolaos Sousos; Bethan Psaila; Adam J Mead; Gareth D H Turner; Gabrielle Rees; Jens Rittscher; Daniel Royston
Journal:  Blood Adv       Date:  2020-07-28

Review 4.  Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.

Authors:  Hussein Awada; Carmelo Gurnari; Arda Durmaz; Hassan Awada; Simona Pagliuca; Valeria Visconte
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

5.  Evaluation of two semi-supervised learning methods and their combination for automatic classification of bone marrow cells.

Authors:  Iori Nakamura; Haruhi Ida; Mayu Yabuta; Wataru Kashiwa; Maho Tsukamoto; Shigeki Sato; Syuichi Ota; Naoki Kobayashi; Hiromi Masauzi; Kazunori Okada; Sanae Kaga; Keiko Miwa; Hiroshi Kanai; Nobuo Masauzi
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

6.  Assessment of dysplasia in bone marrow smear with convolutional neural network.

Authors:  Jinichi Mori; Shizuo Kaji; Hiroki Kawai; Satoshi Kida; Masaharu Tsubokura; Masahiko Fukatsu; Kayo Harada; Hideyoshi Noji; Takayuki Ikezoe; Tomoya Maeda; Akira Matsuda
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

7.  Automatic Detection of Coronary Metallic Stent Struts Based on YOLOv3 and R-FCN.

Authors:  Xiaolu Jiang; Yanqiu Zeng; Shixiao Xiao; Shaojie He; Caizhi Ye; Yu Qi; Jiangsheng Zhao; Dezhi Wei; Muhua Hu; Fei Chen
Journal:  Comput Math Methods Med       Date:  2020-09-01       Impact factor: 2.238

Review 8.  How artificial intelligence might disrupt diagnostics in hematology in the near future.

Authors:  Wencke Walter; Claudia Haferlach; Niroshan Nadarajah; Ines Schmidts; Constanze Kühn; Wolfgang Kern; Torsten Haferlach
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.